Abstract:Abstract Backgrounds: This study aimed to summarize and analyze the clinicopathological features of acute kidney disease patients with renal oxalosis, to improve understanding of the disease characteristics. Methods: Data for patients with acute kidney disease (AKD) diagnosed from January 2011 to October 2018 and confirmed by renal biopsy showing oxalate crystal deposition were collected. The underlying diseases, dietary habits before disease onset, pathological characteristics of newly emerging kidney disease, renal oxalosis, and causes of AKD were analyzed. Urine volume, serum creatinine, uric acid, and electrolyte clearance were recorded. The long-term renal prognosis was observed. Results: A total of 23 patients with AKD and renal oxalosis were included. The patients comprised 18 men (78.3%) and 5 women (21.7%) with a mean age of 51.6 ± 15.9 years. The peak serum creatinine was 669.9 ± 299.8 μmol/L, and 95.7% of patients had stage 3 acute kidney injury. Drug-induced AKD was the most common cause (65.2%), followed by severe nephrotic syndrome (17.4%). Other causes included severe glomerulonephritis, and infection. All patients had pathological changes indicating tubulointerstitial disease (TIN), and 11 patients were complicated with newly emerging glomerular disease (GD). Oxalate deposits caused by increased enterogenous oxalate absorption accounted for 26.1%, and most of the causes came from new kidney diseases. Oxalate crystals were located in the renal tubule. The majority (75%) of moderate to severe oxalate crystal deposition occurred in patients without GD. There were no significant differences in the total score for acute tubulointerstitial injury, score for tubular injury (T-IS), and score for interstitial inflammation in patients with different severities of renal oxalosis. Rate of serum creatinine decrease (ΔScr%) was negatively correlated with severity of oxalosis (R = −0.542, P = 0.037), score for acute tubular injury (R = −0.553, P = 0.033), and age (R = −0.736, P = 0.002). ΔScr% at week 4 was correlated with T-IS (R = −0.433, P = 0.050), but was not correlated with severity of oxalosis. Conclusions: The present findings revealed that 95.7% of AKD cases with renal oxalosis occurred in critically ill patients, secondary to kidney injury with tubular injury, and that drug-induced AKD was the most common cause. Severe oxalosis contributed to delayed early recovery of renal function.

Determinants and impact of calcium oxalate crystal deposition on renal outcomes in acute kidney injury patients

Determinants on urinary excretion of oxalate and other key factors related to urolithiasis among patients with chronic kidney disease: a single center study

The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury

Severe Oxalosis Secondary to Acute Kidney Disease Contributes to Delayed Early Recovery of Renal Function

Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys

Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury

Shock Wave Induced Kidney Injury Promotes Calcium Oxalate Deposition

Influence of Oxalic Acid and Calcium Oxalate Monohydrate Crystals on Human Renal Tubular Epithelial Cells

Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies

[Epidemiology of Acute Kidney Injury in Hospitalized Patients in China].

Association Between Mineral and Bone Disorder in Patients with Acute Kidney Injury Following Cardiac Surgery and Adverse Outcomes

Prevalence and clinical association of hyperechoic crystal deposits on ultrasonography in patients with chronic kidney disease: a cross-sectional study from a single center

[Study on nano- and microcrystallites in the urines of calcium oxalate stone formers]

CXCR4 inhibition attenuates calcium oxalate crystal deposition-induced renal fibrosis

Analysis of HK-2 Cells Exposed to Oxalate and Calcium Oxalate Crystals: Proteomic Insights into the Molecular Mechanisms of Renal Injury and Stone Formation

Calcium Oxalate Crystals Induce Renal Inflammation by NLRP3-mediated IL-1β Secretion

The advances of calcium oxalate calculi associated drugs and targets

Oxalate-induced apoptosis through ERS-ROS–NF-κB signalling pathway in renal tubular epithelial cell

Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites

Severe acute kidney injury due to oxalate crystal induced severe interstitial nephritis: A case report

PPARγ agonist alleviates calcium oxalate nephrolithiasis by regulating mitochondrial dynamics in renal tubular epithelial cell